US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 6.510
  • -0.200-2.98%
Close Apr 25 16:00 ET
  • 6.510
  • 0.0000.00%
Post 16:20 ET
115.68MMarket Cap-4552P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
19.04%22.9M
1.30%6.87M
3.70%6.16M
61.54%5.77M
39.25%4.1M
49.17%19.23M
199.25%6.78M
27.21%5.94M
-39.83%3.57M
12,704.35%2.95M
Selling and administrative expenses
25.14%7.52M
9.24%2.6M
17.91%1.67M
41.39%1.51M
52.11%1.73M
79.37%6.01M
112.40%2.38M
176.95%1.42M
-36.92%1.07M
4,856.52%1.14M
-General and administrative expense
25.14%7.52M
9.24%2.6M
17.91%1.67M
41.39%1.51M
52.11%1.73M
79.37%6.01M
112.40%2.38M
176.95%1.42M
-36.92%1.07M
4,856.52%1.14M
Research and development costs
16.28%15.38M
-3.00%4.27M
-0.75%4.49M
70.14%4.26M
31.14%2.37M
38.58%13.23M
284.35%4.4M
8.76%4.52M
-40.99%2.51M
--1.81M
Operating profit
-19.04%-22.9M
-1.30%-6.87M
-3.70%-6.16M
-61.54%-5.77M
-39.25%-4.1M
-49.17%-19.23M
-199.25%-6.78M
-27.21%-5.94M
39.83%-3.57M
-12,704.35%-2.95M
Net non-operating interest income expense
327.52%637K
197.56%244K
354.10%277K
1,500.00%64K
2,500.00%52K
3,625.00%149K
1,950.00%82K
61K
4K
2K
Non-operating interest income
327.52%637K
197.56%244K
354.10%277K
1,500.00%64K
2,500.00%52K
3,625.00%149K
1,950.00%82K
--61K
--4K
--2K
Other net income (expense)
Income before tax
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
39.90%-3.57M
-12,695.65%-2.94M
Income tax
Net income
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
39.90%-3.57M
-12,695.65%-2.94M
Net income continuous Operations
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
39.90%-3.57M
-12,695.65%-2.94M
Minority interest income
Net income attributable to the parent company
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
39.90%-3.57M
-12,695.65%-2.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
-25.90%-5.88M
39.90%-3.57M
-12,695.65%-2.94M
Basic earnings per share
5.30%-1.43
14.58%-0.41
11.90%-0.37
-35.71%-0.38
15.63%-0.27
-38.44%-1.51
-150.89%-0.48
-6.33%-0.42
40.03%-0.28
-17,599.12%-0.32
Diluted earnings per share
5.30%-1.43
14.58%-0.41
11.90%-0.37
-35.71%-0.38
15.63%-0.27
-38.44%-1.51
-150.89%-0.48
-6.33%-0.42
40.03%-0.28
-17,599.12%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 19.04%22.9M1.30%6.87M3.70%6.16M61.54%5.77M39.25%4.1M49.17%19.23M199.25%6.78M27.21%5.94M-39.83%3.57M12,704.35%2.95M
Selling and administrative expenses 25.14%7.52M9.24%2.6M17.91%1.67M41.39%1.51M52.11%1.73M79.37%6.01M112.40%2.38M176.95%1.42M-36.92%1.07M4,856.52%1.14M
-General and administrative expense 25.14%7.52M9.24%2.6M17.91%1.67M41.39%1.51M52.11%1.73M79.37%6.01M112.40%2.38M176.95%1.42M-36.92%1.07M4,856.52%1.14M
Research and development costs 16.28%15.38M-3.00%4.27M-0.75%4.49M70.14%4.26M31.14%2.37M38.58%13.23M284.35%4.4M8.76%4.52M-40.99%2.51M--1.81M
Operating profit -19.04%-22.9M-1.30%-6.87M-3.70%-6.16M-61.54%-5.77M-39.25%-4.1M-49.17%-19.23M-199.25%-6.78M-27.21%-5.94M39.83%-3.57M-12,704.35%-2.95M
Net non-operating interest income expense 327.52%637K197.56%244K354.10%277K1,500.00%64K2,500.00%52K3,625.00%149K1,950.00%82K61K4K2K
Non-operating interest income 327.52%637K197.56%244K354.10%277K1,500.00%64K2,500.00%52K3,625.00%149K1,950.00%82K--61K--4K--2K
Other net income (expense)
Income before tax -16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M39.90%-3.57M-12,695.65%-2.94M
Income tax
Net income -16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M39.90%-3.57M-12,695.65%-2.94M
Net income continuous Operations -16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M39.90%-3.57M-12,695.65%-2.94M
Minority interest income
Net income attributable to the parent company -16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M39.90%-3.57M-12,695.65%-2.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M-25.90%-5.88M39.90%-3.57M-12,695.65%-2.94M
Basic earnings per share 5.30%-1.4314.58%-0.4111.90%-0.37-35.71%-0.3815.63%-0.27-38.44%-1.51-150.89%-0.48-6.33%-0.4240.03%-0.28-17,599.12%-0.32
Diluted earnings per share 5.30%-1.4314.58%-0.4111.90%-0.37-35.71%-0.3815.63%-0.27-38.44%-1.51-150.89%-0.48-6.33%-0.4240.03%-0.28-17,599.12%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg